Healthcare
The Bolt-Ons Digest – 26 January 2023
Unquote’s selection of the latest add-ons, with ICG's Circet, Five Arrows' Mintec, Carlyle's Jagex, and more
German health minister’s 'locust sponsors' comments spook live healthcare deals
New entrants scared by remarks on limiting profits; existing investors expected to rush to complete bolt-ons
IK readies Swedish biotech group Mabtech for exit
Jefferies hired as sellside advisor; dual-track process for potential sale or IPO considered
EQT on track for 2023 final close for Fund X
GP has so far raised more than EUR 16bn for the vehicle against EUR 20bn target
Montagu exits Maincare to state-owned Docaposte in off-market deal
Hospital software group considered "missing piece" in buyer's healthcare digitalisation strategy
IK launches mini-cap strategy in UK and Benelux with robust pipeline
With a focus on deals of up to EUR 50m EV, the GP's Development Capital team is in advanced negotiations with several potential targets in the new markets
Inflexion acquires minority stake in Proteros
Deal for German contract research organisation is the sponsor's third in pharma services in past 12 months
Arcano holds EUR 280m final close for impact fund-of-funds
Spanish GP is eyeing a second vintage in 2023 with the vehicle more than 50% deployed
AG Capital kicks off inaugural fund with Improove buyout
Austrian emerging manager acquires local SEO agency with country's first buyout fund in a decade
Permira announces changes in DACH leadership
Jörg Rockenhäuser to become region’s first chairman as Florian Kreuzer succeeds him as head of DACH
FSI eyes new fund with near EUR 1bn returned to LPs this year
Italian GP conducted three exits in 2022; Fund II would have similar size as EUR 1.4bn predecessor
Women in VC: Speedinvest’s Nangia on supporting female and underrepresented founders
Austrian sponsor to invest 30% of capital in female, diverse founders; new fund-of-funds set to support emerging managers
Private Equity Trendspotter: Sponsors look for sure footing as market slowdown signals change in deals landscape
Aggregate buyout volume brings 2022 just 6% above pre-pandemic dealmaking, with a significant sentiment shift in H2 2022
The Bolt-Ons Digest – 14 December 2022
Unquote’s selection of the latest add-ons, including CVC's Stark Group, Bridgepoint's Kereis, EQT's Open Systems, and more
EQT moves SHL Medical stake into long-term strategy fund
Family office ATHOS is co-investing in the deal, which sees the Swiss drug autoinjector group exit EQT VIII
Female Founders plans final close for EUR 20m debut fund in Q3 2023
Vienna-based VC investing in women-led teams held first close on EUR 12m in October
KKR buys Clinisupplies to build chronic care medical devices platform
GP installs former Atos CEO as chairman; deal is partial exit for Apax Partners' India-based Healthium
H2 turns to bilateral talks to get Optegra sale over the line, sources say
Deal with MidEuropa sealed after auction for ophthalmology group went quiet earlier this month
MidEuropa takes majority stake in Optegra
H2 Equity reinvests with minority share; sale saw interest from Partners, HIG, CapVest
Meanings primes second midcap fund for final close by Q2 2023
With a EUR 300m hard cap, the fund could complete its first investment by H1 2023
Eurazeo, GA-backed Doctolib weighs growth financing options
Appointment booking platform is holding preliminary talks for its next growth milestone
Women in PE: Triton’s Meier-Kirner on deploying in times of crisis and resisting herd mentality
Pan-European sponsor aims to back undervalued businesses and those with structural tailwinds using learnings from past crises
Armonia exits Italy’s BioDue in SBO to Riverside Europe
Sale of food supplement and medical devices group marks second exit from Armònia Italy Fund
CapMan to return to market for new growth fund in 2024
With EUR 100m-150m target, fundraising will launch after CapMan Growth II's full deployment
